Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
ACHFF
Primary Symbol:
V.ARCH
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok...
). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Dec 15, 2021 3:25pm
RE:RE:RE:RE:Down 30% off the highs
Large institutions are constrained by covenant issues regarding drugs in phase II and also by the thin float. Once phase II trials are independently verified - we should see substantial volume
...more
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Dec 15, 2021 3:04pm
RE:Adding to positive vibes
"Metablok is the first novel therapeutic to enter the CATCO Trial, which has so far tested generic drugs such as remdesivir, dexamethasone, and hydroxychloroquine." This is the exciting
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Dec 15, 2021 2:14pm
Adding to positive vibes
https://www.wfmz.com/news/pr_newswire/pr_newswire_health/dalton-pharma-services-supports-manufacturing-of-arch-biopartners-lsalt-peptide/article_c10d573a-c063-5812-9661-7c23f63ed00b.html Dalton
...more
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Dec 15, 2021 11:09am
RE:RE:RE:Down 30% off the highs
No concern whatsoever about fundamentals. based on the achievements in the last 18 months, this should be a $15 stock if not more right now. The question is... why isn't it, and what forces
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Dec 15, 2021 10:13am
RE:RE:Down 30% off the highs
This is just the beginning and all signs are positive. Speculators jumped ship and weak hands bailed as well. Good for me in getting more shares. What to look forward to: Sunnybrook Research
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Dec 14, 2021 10:03pm
RE:Down 30% off the highs
I think that any opportunity to buy at these depressed levels before first dose of Phase III is a gift.
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Dec 14, 2021 3:13pm
Down 30% off the highs
Anybody have insight into where this ends? We're assuming third party data news is the kicker here. But as the share price continues to slide, doesn't it imply that our ability to uplist
...more
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Dec 13, 2021 10:21am
BLU up on Phase 2B
Just look at the volume that comes with being listed in the US. 56M shares traded so far in the US, about 100x relative volume.
(93)
•••
SrPlata
X
View Profile
View Bullboard History
Comment by
SrPlata
on Dec 12, 2021 12:28pm
RE:Another Reason Why this is my largest holding - Insider Buy
On the surface it does not look like that big of a insider purchase of roughly 10k however if you take into consideration the annual salary of RM of only 100k CDN it comes out to 10% of his
...more
(17)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Dec 11, 2021 6:24pm
Another Reason Why this is my largest holding - Insider Buy
Dec 8/21 CEO Muruve, Richard Gabriel Direct Ownership Public market buy Common Shares 3.97 2,500 0.0% 8,577,700
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Dec 10, 2021 1:34pm
Traders taking Friday off
No action today. We need third party data and uplisting plans ASAP. Hoping it's a US third party.
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Dec 10, 2021 9:27am
RE:Keep your stick on the ice
Added 7k more shares ytd under 4.10. There aren't going to be deals like this much longer.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Dec 10, 2021 9:25am
Keep your stick on the ice
The stock that we all knew is gone, their is often ice on both the bid and ask these day, play safe!
(17)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Dec 09, 2021 7:57pm
Todays House Positions
House Positions for C:ARCH from 20211209 to 20211209 House Bought $Val Ave Sold $Val
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year